» Articles » PMID: 33330670

Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering

Overview
Date 2020 Dec 17
PMID 33330670
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Stratified medicine may enable the development of effective treatments for particular groups of patients with heart failure with preserved ejection fraction (HFpEF); however, the heterogeneity of this syndrome makes it difficult to group patients together by common disease features. The aim of the present study was to find new subgroups of HFpEF using machine learning. K-means clustering was used to stratify patients with HFpEF. We retrospectively enrolled 350 outpatients with HFpEF. Their clinical characteristics, blood sample test results and hemodynamic parameters assessed by echocardiography, electrocardiography and jugular venous pulse, and clinical outcomes were applied to k-means clustering. The optimal k was detected using Hartigan's rule. HFpEF was stratified into four groups. The characteristic feature in group 1 was left ventricular relaxation abnormality. Compared with group 1, patients in groups 2, 3, and 4 had a high mean mitral E/e' ratio. The estimated glomerular filtration rate was lower in group 2 than in group 3 (median 51 ml/min/1.73 m vs. 63 ml/min/1.73 m < 0.05). The prevalence of less-distensible right ventricle and atrial fibrillation was higher, and the deceleration time of mitral inflow was shorter in group 3 than in group 2 (93 vs. 22% < 0.05, 95 vs. 1% < 0.05, and median 167 vs. 223 ms < 0.05, respectively). Group 4 was characterized by older age (median 85 years) and had a high systolic pulmonary arterial pressure (median 37 mmHg), less-distensible right ventricle (89%) and renal dysfunction (median 54 ml/min/1.73 m). Compared with group 1, group 4 exhibited the highest risk of the cardiac events (hazard ratio [HR]: 19; 95% confidence interval [CI] 8.9-41); group 2 and 3 demonstrated similar rates of cardiac events (group 2 HR: 5.1; 95% CI 2.2-12; group 3 HR: 3.7; 95%CI, 1.3-10). The event-free rates were the lowest in group 4 ( for trend < 0.001). K-means clustering divided HFpEF into 4 groups. Older patients with HFpEF may suffer from complication of RV afterload mismatch and renal dysfunction. Our study may be useful for stratified medicine for HFpEF.

Citing Articles

Unsupervised clustering analysis of treatment strategies for elite female athletes with severe stress urinary incontinence: focusing on competition return and SUI improvement.

Okui N, Okui M Int Urol Nephrol. 2024; .

PMID: 39733386 DOI: 10.1007/s11255-024-04337-6.


Detecting cardiovascular diseases using unsupervised machine learning clustering based on electronic medical records.

Hu Y, Yan H, Liu M, Gao J, Xie L, Zhang C BMC Med Res Methodol. 2024; 24(1):309.

PMID: 39702064 PMC: 11658374. DOI: 10.1186/s12874-024-02422-z.


Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects.

Chen X, Huang M, Chen Y, Xu H, Wu M Heart Fail Rev. 2024; 30(1):191-208.

PMID: 39414721 DOI: 10.1007/s10741-024-10455-1.


Multifaced risk factors and clinical impact of a deep Y descent in patients with heart failure irrespective of RV-PA coupling.

Harada D, Noto T, Takagawa J Int J Cardiol Heart Vasc. 2024; 53:101439.

PMID: 38939016 PMC: 11209010. DOI: 10.1016/j.ijcha.2024.101439.


Development of interpretable machine learning models to predict in-hospital prognosis of acute heart failure patients.

Tanaka M, Kohjitani H, Yamamoto E, Morimoto T, Kato T, Yaku H ESC Heart Fail. 2024; 11(5):2798-2812.

PMID: 38751135 PMC: 11424291. DOI: 10.1002/ehf2.14834.


References
1.
Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral F, Cobo-Marcos M, Robles C . Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015; 36(38):2585-94. DOI: 10.1093/eurheartj/ehv338. View

2.
Nishimura R, Tajik A . Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol. 1997; 30(1):8-18. DOI: 10.1016/s0735-1097(97)00144-7. View

3.
Samson R, Jaiswal A, Ennezat P, Cassidy M, Le Jemtel T . Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2016; 5(1). PMC: 4859363. DOI: 10.1161/JAHA.115.002477. View

4.
Haldar P, Pavord I, Shaw D, Berry M, Thomas M, Brightling C . Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008; 178(3):218-224. PMC: 3992366. DOI: 10.1164/rccm.200711-1754OC. View

5.
Shah S, Katz D, Selvaraj S, Burke M, Yancy C, Gheorghiade M . Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2014; 131(3):269-79. PMC: 4302027. DOI: 10.1161/CIRCULATIONAHA.114.010637. View